FGF9 and colorectal carcinoma: Although clinicopathological analysis revealed that levels of FGF9 protein were not associated with disease stage (data not shown), we did find FGF9 expression was significantly higher in primary liver metastasized CRC than recurrent liver metastasized CRC from the same patient (Figure 6E, P < 0.01).